Lack of association between the MTHFR (C677T) polymorphism and atopic disease

Betina Heinsbaek Thuesen1, Lise Lotte Nystrup Husemoen, Mogens Fenger

  • 1Research Centre for Prevention and Health, Glostrup University Hospital, Nordre Ringvej 57, Glostrup, Denmark. beheth01@glo.regionh.dk

Abstract

Insights

This study found no significant link between the MTHFR gene variant, a marker for folate metabolism, and the development of asthma or atopic disease. These findings do not support the hypothesis that impaired folate metabolism contributes to these conditions.

Area of Science:

  • Genetics and Immunology
  • Environmental Health

Background:

  • Impaired folate metabolism is a potential risk factor for asthma and atopic disease.
  • Conflicting reports exist regarding the association between atopic disease and the MTHFR (C677T) gene polymorphism.

Purpose of the Study:

  • To investigate the association between the MTHFR (C677T) polymorphism and asthma/atopic disease outcomes.
  • To clarify the role of folate metabolism in the development of allergic conditions.

Main Methods:

  • Population-based study of 1189 participants (aged 15-77) in Copenhagen.
  • Assessed specific IgE, skin prick tests, methacholine bronchial hyper-reactivity, and serum eosinophilic cationic protein.
  • Genotyped participants for the MTHFR (C677T) polymorphism and used questionnaires for allergy/asthma symptoms.

Main Results:

  • No significant associations were found between the MTHFR (C677T) polymorphism and any of the measured asthma or atopic disease outcomes.
  • Objective markers of atopic disease showed no correlation with the MTHFR genotype.

Conclusions:

  • The study's findings do not support the hypothesis linking impaired folate metabolism, indicated by MTHFR genotype, to the development of atopic disease.
  • Objective assessment of atopic disease markers did not confirm a role for MTHFR in disease development.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Epistasis01:39

Epistasis

In addition to multiple alleles at the same locus influencing traits, numerous genes or alleles at different locations may interact and influence phenotypes in a phenomenon called epistasis. For example, rabbit fur can be black or brown depending on whether the animal is homozygous dominant or heterozygous at a TYRP1 locus. However, if the rabbit is also homozygous recessive at a locus on the tyrosinase gene (TYR), it will have an unshaded coat that appears white, regardless of its TYRP1...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair01:36

Mismatch Repair

Overview
Mutations01:39

Mutations

Overview